
Gallmetzer Healthcare is a parent of specialised research, development, production and distribution businesses serving dentists, dental laboratories and healthcare practices.
gallmetzerhealthcare.comCrawled Nov 8, 2026
Since 1 November 2026, Gallmetzer Healthcare S.p.A. shares have traded continuously on the Vienna Stock Exchange’s Direct Market Plus segment, replacing the previous auction system.
Gallmetzer HealthCare AG’s management includes an experienced executive team and independent governing bodies. These groups collaborate to ensure stability, integrity, and long-term growth, with clear roles for the Executive Board, Board of Directors, and Supervisory Board.
As an operational holding company, we manage a network of highly specialized subsidiaries active in research, development, production and distribution with a strong focus on dental products and innovative solutions in the pharmaceutical and healthcare sectors.
Gallmetzer HealthCare S.p.A. discloses manager transactions as required by **Article 19 of the EU Market Abuse Regulation (MAR)**. The announcement follows regulatory reporting obligations for insider dealings or corporate actions by company executives or directors. No specific details on transaction type, volume, or identities are provided in the brief filing.
Nov 2026TradingViewNews article
Dietrich Gallmetzer, CEO of Gallmetzer HealthCare S.p.A., disposes of 10 shares through his holding company, Gallmetzer Holding SRL. The transaction occurs at €3.50 per share on November 2, 2026, with Gallmetzer retaining 99% ownership of the holding entity.
Nov 2026TradingViewNews article
Gallmetzer HealthCare S.p.A. discloses managerial transactions under Article 19 MAR. The announcement details a notification from Gallmetzer Holding SRL, a closely associated entity, though specific reasons or transaction details remain unspecified in the report.
Nov 2026TradingViewNews article
Gallmetzer HealthCare SpA is broadening its presence in the anesthetics market through strategic acquisitions and trading activities. The company leverages its portfolio to strengthen its position in specialized healthcare solutions. This move aligns with its focus on expanding operational reach in the medical sector.
Nov 2026WebDisclosureNews article